Dalhousie research team prepares for clinical trial of COVID-19 vaccine
2020-03-25 from cbc.ca
A Dalhousie University researcher at the forefront of Canada's quest to find a treatment for COVID-19 says human trials for a promising new vaccine could be only weeks away.
Dalhousie's COVID-19 rapid response team is moving forward with testing a vaccine that uses a genome of DNA from SARS CoV-2, the virus that causes COVID-19.
"We're beginning to evaluate this in animal models and we can even bring this into people for Phase 1 clinical trials as soon as three weeks from now," virologist Alyson Kelvin told CBC's Information Morning on Wednesday.
"Right now, DNA vaccines have been shown to be safe and effective in people, so we hope that this will help expedite the process of vaccine development."
Read more here